Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Marriott Wardman Park Hotel

27 ene 2020 7:00 a.m. - 29 ene 2020 4:15 p.m.

2660 Woodley Road, NW, , Washington, DC 20008 , USA

Pharmacovigilance and Risk Management Strategies Conference

Session 5: Hot Topics – Handling Emerging Trends in Pharmacovigilance

Session Chair(s)

Barbara  Morollo, RN

Barbara Morollo, RN

Head, Pharmacovigilance

Corbus Pharmaceuticals, United States

Catherine  Baldridge, MSc

Catherine Baldridge, MSc

Head of Safety

Fusion Pharmaceuticals, United States

This session will explore three hot topics and emerging trends in pharmacovigilance which include spanning discussions regarding predictive safety using translational data and non-clinical data for predicting ADRs, the impact of cannabinoids as therapeutics and research into the endocannabinoid system.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Understand the technology and factors that contribute to the ability to predict an adverse events or adverse event in a specific population
  • Identify the unique regulatory challenges surrounding cannabis and studying therapeutic benefits in investigational research

Speaker(s)

Barbara  Morollo, RN

Cannabinoids as Therapeutics

Barbara Morollo, RN

Corbus Pharmaceuticals, United States

Head, Pharmacovigilance

Glenn  Carroll, MBA

Speaker

Glenn Carroll, MBA

Deloitte, United States

Principal

Sarah  Vaughan

Yellow Card Biobank

Sarah Vaughan

Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Head of Vigilance Operations

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.